Abstract
BackgroundThe potent immunosuppressive properties of sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) on myeloid cells and lymphocytes provide a strong rationale for serving as a therapeutic target. However, the expression profile and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have